/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Kiniksa Pharmaceuticals International Plc Share Price Today: Live Updates & Key Insights

Kiniksa Pharmaceuticals International Plc share price today is $46.08, up 0.99%. The stock opened at $46.155 against the previous close of $45.63, with an intraday high of $46.34 and low of $45.01.

Kiniksa Pharmaceuticals International Plc Share Price Chart

style
pb-0

Kiniksa Pharmaceuticals International Plc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Kiniksa Pharmaceuticals International Plc Share Price Performance

$46.08 0.0099(0.99%) KNSA at 23 Mar 2026 01:53 PM Drug Manufacturers - Specialty & Generic
Lowest Today 45.01
Highest Today 46.34
Today’s Open 46.155
Prev. Close 45.63
52 Week High 49.12
52 Week Low 18.26
Day’s Range: Low 45.01 High 46.34
52-Week Range: Low 18.26 High 49.12
1 day return -
1 Week return -0.94
1 month return -2.74
3 month return +5.77
6 month return +27.74
1 year return +96.54
3 year return +312.72
5 year return +138.96
10 year return -

Kiniksa Pharmaceuticals International Plc Institutional Holdings

Rockefeller Capital Management L.P. 9.35

Rubric Capital Management LP 4.35

Vanguard Group Inc 4.07

Baker Bros Advisors LP 3.69

TANG CAPITAL MANAGEMENT LLC 3.04

FMR Inc 2.15

Acadian Asset Management LLC 2.11

Morgan Stanley - Brokerage Accounts 1.78

Fairmount Funds Management LLC 1.72

D. E. Shaw & Co LP 1.62

Vanguard Total Stock Mkt Idx Inv 1.60

Arrowstreet Capital Limited Partnership 1.40

Vanguard Small Cap Index 1.20

BNP Paribas Arbitrage, SA 1.09

Millennium Management LLC 1.08

Pictet Asset Manangement SA 1.03

Qube Research & Technologies 1.00

Citadel Advisors Llc 0.97

Connor Clark & Lunn Inv Mgmt Ltd 0.97

Dimensional Fund Advisors, Inc. 0.89

Parkman Healthcare Partners LLC 0.87

Driehaus Capital Management LLC 0.83

Fidelity Select Health Care 0.82

Vanguard Small Cap Growth Index Inv 0.67

Pictet-Biotech P USD 0.66

Fidelity Small Cap Growth 0.64

Strategic Advisers Fidelity US TtlStk 0.52

AB Intl Health Care AX USD 0.47

Victory Trivalent International Sm-Cp I 0.43

GS Glb Sm Cp CORE Eq Base Inc USD Close 0.40

Oberweis Micro-Cap 0.40

Oberweis Micro-Cap Growth 0.40

Xtrackers MSCI USA Swap ETF 1C 0.39

MFS New Discovery I 0.39

Fidelity Advisor Health Care I 0.35

Heptagon Driehaus US Micro Cap Eq C$ Acc 0.33

Fidelity Small Cap Growth K6 0.30

Pictet-Global Megatrend Sel I USD 0.29

Penn Capital Small Cap Equity 0.27

abrdn US Equity Small Cap 0.20

Kiniksa Pharmaceuticals International Plc Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Kiniksa Pharmaceuticals International Plc Fundamentals

Market Cap 3526.75 M

PB Ratio 6.2134

PE Ratio 60.6316

Enterprise Value 3122.17 M

Total Assets 763.63 M

Volume 852482

Kiniksa Pharmaceuticals International Plc Company Financials

Annual Revenue FY25:677564000 677.6M, FY24:423239000 423.2M, FY23:248748000 248.7M, FY22:220180000 220.2M, FY21:38544000 38.5M

Annual Profit FY25:null 0.0M, FY24:423239000 423.2M, FY23:195179000 195.2M, FY22:173214000 173.2M, FY21:29444000 29.4M

Annual Net worth FY25:118731000 118.7M, FY24:-43193000 -43.2M, FY23:-6692000 -6.7M, FY22:183363000 183.4M, FY21:-157924000 -157.9M

Quarterly Revenue Q4/2025:202127000 202.1M, Q3/2025:180855000 180.9M, Q2/2025:156797000 156.8M, Q1/2025:137785000 137.8M, Q3/2024:112214000 112.2M

Quarterly Profit Q4/2025:-259154000 -259.2M, Q3/2025:97264000 97.3M, Q2/2025:85763000 85.8M, Q1/2025:76127000 76.1M, Q3/2024:62798000 62.8M

Quarterly Net worth Q4/2025:73925000 73.9M, Q3/2025:18435000 18.4M, Q2/2025:17832000 17.8M, Q1/2025:8539000 8.5M, Q3/2024:-12693000 -12.7M

About Kiniksa Pharmaceuticals International Plc & investment objective

Company Information Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.

Organisation Drug Manufacturers - Specialty & Generic

Employees 366

Industry Drug Manufacturers - Specialty & Generic

CEO Mr. Sanj K. Patel

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Kiniksa Pharmaceuticals International Plc FAQs

What is the share price of Kiniksa Pharmaceuticals International Plc today?

The current share price of Kiniksa Pharmaceuticals International Plc is $46.08.

Can I buy Kiniksa Pharmaceuticals International Plc shares in India?

Yes, Indian investors can buy Kiniksa Pharmaceuticals International Plc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Kiniksa Pharmaceuticals International Plc shares in India?

You can easily invest in Kiniksa Pharmaceuticals International Plc shares from India by:

Can I buy fractional shares of Kiniksa Pharmaceuticals International Plc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Kiniksa Pharmaceuticals International Plc?

Kiniksa Pharmaceuticals International Plc has a market cap of $3526.75 M.

In which sector does Kiniksa Pharmaceuticals International Plc belong?

Kiniksa Pharmaceuticals International Plc operates in the Drug Manufacturers - Specialty & Generic sector.

What documents are required to invest in Kiniksa Pharmaceuticals International Plc stocks?

To invest, you typically need:

What is the PE and PB ratio of Kiniksa Pharmaceuticals International Plc?

The PE ratio of Kiniksa Pharmaceuticals International Plc is 60.63 and the PB ratio is 6.21.